VAXART (VXRT)
(Delayed Data from NSDQ)
$0.61 USD
+0.02 (2.91%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $0.62 +0.01 (2.04%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 42% (105 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | 0.03 | -2.04 | 61.00 |
Year Ago Quarter Estimate | -0.16 | -0.59 | 54.84 |
Next Quarter Estimate | -0.12 | -2.00 | 63.00 |
Next Year Estimate | -0.50 | 6.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 3.51 | 13.50 | 15.67 |
Next Year | 9.09 | 16.70 | 11.34 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 24.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 1.87 | 1.58 |
Price/Cash Flow (MRFY) | NA | 8.47 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -920.00% | 6.02% |
Return on Equity (TTM) | -121.06% | 7.75% |
Debt to Equity (MRQ) | NA | 2.23 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.